43.30
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 43.30 | 0.00 | 0.00 | 0.00 | 43.30 | 04:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 42.11 | 45.10 | 2.99 | 6.63% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 43.30 | USD |
Agios Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.98B | 68.89M | 44.41M | $ 117.91M | $ - | -6.86 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.50 | 50.18 | 43.09 | 45.42 | 690,319 | -5.20 | -10.72% |
| 1 Month | 55.13 | 56.22 | 43.09 | 49.88 | 512,126 | -11.83 | -21.46% |
| 3 Months | 45.18 | 56.745 | 43.00 | 50.45 | 631,693 | -1.88 | -4.16% |
| 6 Months | 49.82 | 56.745 | 27.774 | 45.66 | 672,005 | -6.52 | -13.09% |
| 1 Year | 39.94 | 56.745 | 27.774 | 42.65 | 713,709 | 3.36 | 8.41% |
| 3 Years | 61.14 | 99.8242 | 27.774 | 55.39 | 547,915 | -17.84 | -29.18% |
| 5 Years | 105.46 | 109.08 | 27.774 | 54.20 | 595,083 | -62.16 | -58.94% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
